NCT01477801View on ClinicalTrials.gov

Effects of Cholecalciferol Supplementation in Patients With Chronic Heart Failure and LOw vITamind D Levels

PHASE2/PHASE3UnknownINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

July 31, 2012

Study Completion Date

September 30, 2012

Conditions
Heart FailureVitamin D Deficiency
Interventions
DRUG

CHOLECALCIFEROL

"Standard guideline based therapy plus cholecalciferol:~Loading dose 300.000 U then 50.000 U every month for six months"

DRUG

PLACEBO

Standard guideline based therapy plus placebo

Trial Locations (1)

41100

RECRUITING

Medicina Cardiovascolare - NOCSAE - Azienda USL, Modena

Sponsors

Collaborators (1)

Abiogen Pharma
All Listed Sponsors
collaborator

Abiogen Pharma

INDUSTRY

lead

Azienda Unita' Sanitaria Locale Di Modena

OTHER